L-Leucine → 2-{(S)-[(4-bromophenyl)-thiazol-2-yl-methyl)-amino)-4-methylpentanoic acid (1-cyanocyclopropyl)-amide

Participants

Role	Name	HCID	Charge
Reactant	L-Leucine	HCID 6106	—
Reactant	Diisopropylamine	HCID 7912	—
Reactant	Thiazole	HCID 9256	—
Reactant	1-Aminocyclopropanecarbonitrile	HCID 556888	—
Reactant	Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)	HCID 9886157	—
Reactant	3-Methyl-1-(4-methyl-2,6,7-trioxa-bicyclo[2.2.2]oct-1-yl)-butylamine	HCID 57446957	—
Reactant	(2S)-2-{(S)-[(4-bromophenyl)thiazol-2-yl-methyl]-amino}-4-methylpentanoic acid	HCID 67298316	—
Reactant	HCID 178506677	HCID 178506677	—
Product	2-{(S)-[(4-bromophenyl)-thiazol-2-yl-methyl)-amino)-4-methylpentanoic acid (1-cyanocyclopropyl)-amide	HCID 86590556	—

Reaction Steps

The title compound was prepared by the coupling of (2S)-2-{(S)-[(4-bromophenyl)-thiazol-2-yl-methyl]-amino}-4-methylpentanoic acid with 1-aminocyclopropanecarbonitrile in the presence of HATU and diisopropylamine, in similar manner to that described for the preparation of Example 34. The synthesis of (2S)-2-{(S)-[(4-bromophenyl)-thiazol-2-yl-methyl]-amino}-4-methylpentanoic acid was accomplished via addition of bromophenyllithium (generated in situ from 1,4-dibromobenzene and n-butyllithium) to the imine condensation product between thiazole 2-carboxayldehyde and 3-methyl-1-(4-methyl-2,6,7-trioxa-bicyclo[2.2.2]oct-1-yl)-butylamine (L-leucine OBO ester, prepared according to the method described for Example 34), followed by ortho ester deprotection.

Provenance & Evidence

DOI	10.6084/m9.figshare.5104873.v1
Patent number	US07973037B2
Source dataset	uspto-grants-2011_07
ORD ID	ord-be1d2d3831b346c78bf595a325b75d67
Source note	uspto-grants-2011_07